Showing results (1691-1700 of 1,768) with videos related to
Sort By:
Pageof 177
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 26, 2016
Natural History of Cryptosporidiosis in a Birth Cohort in Southern IndiaDeepthi Kattula, Nithya Jeyavelu, Ashok D Prabhakaran, et al.The American Journal of Cardiology|February 8, 2023
Impact of Cardiac Implantable Electronic Devices on Cost and Length of Stay in Patients With Surgical Aortic Valve Replacement and Transcutaneous Aortic Valve ImplantationHiroyuki Sawatari, Anwar A Chahal, Raheel Ahmed, et al.Cancer Cell International|May 7, 2026
In silico screening, synthesis, and biological evaluation of pyrazolopyrimidine-derived mTOR inhibitors for anticancer and senomorphic effectsDavid Rysanek, Zofia Chrienova, Dorota Stary, et al.The Journal of Clinical Endocrinology and Metabolism|January 29, 2025
Endocrine alterations in patients with pachydermoperiostosisMaria Stelmachowska-Banaś, Sayka Barry, Ishita Angurala, et al.Journal of Medicinal Chemistry|January 4, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump InhibitionMousumi Shyam, Harshita Verma, Gourab Bhattacharje, et al.BMJ Open|November 19, 2021
Metastatic prostate cancer men's attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment studyMartin John Connor, Mesfin G Genie, Michael Gonzalez, et al.The Oncologist|May 31, 2022
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141Maura L Gillison, George Blumenschein, Jerome Fayette, et al.Angewandte Chemie (International Ed. in English)|July 12, 2012
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivoMuthusamy Jayaraman, Steven M Ansell, Barbara L Mui, et al.Oral Oncology|June 10, 2018
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expressionRobert L Ferris, George Blumenschein, Jerome Fayette, et al.The Science of the Total Environment|February 19, 2021
COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in QatarJayaprakash Saththasivam, Shimaa S El-Malah, Tricia A Gomez, et al.Pageof 177